LCTX
Lineage Cell Therapeutics Inc
Mentions (24Hr)
0.00% Today
Reddit Posts
Biotech Catalysts This Week ($VSTM $ABUS $ASXC $NMTR $RIGL $PGEN $CTIC $LCTX $ASLN $ZYNE)
Learn en watch ! $LCTX mind blowing
LCTX is a massive sleeping beast that has just awoken. Major catalysts ahead
LCTX is a fucking massive sleeping beast that has just awoken. Major catalysts ahead
Momentum Watchlist for Tuesday, 06/01/21
The potential of $LCTX to dominate a ~ $90B market for a blinding disease with Zero -O - Treatments !
Mentions
Lately I've identified 3 stocks that I think have good daily waves or spreads. I plan to keep buying and selling them, holding them anywhere from less than a day to a few days. I've already invested once in them & have set alerts to buy them when they dip. They are: GLDG,NFGC, LCTX.
LCTX. No brainer.. add 3 years and it will no longer be sub 10 dollars.
Here quick overview of LCTX... (STEM) CELL therapeutics company focused on brining these types of therapies into a regulated market. One of their most exciting projects is OPRegen... it fixes an issue with the eyes in one treatment.. not only stops the degeneration.. but is actually showing to repair it in 36 month Phase 2 trials. It would be amazing to me if it does not come to market at some point between 2027-2028. No surprise.. after their successful announcement of the Phase 2 trials for OPRegen.. now they are getting funding for Diabetes cell therapy treatment. Frankly I was happy just riding this stock as it was.. if they can get great phase 1/2 results for Diabetes treatment.. it could be a major catalyst to see LCTX. Why is LCTX still under $2? Well Biotech tends to either be the best stock you own or it just falls from the sky. Its not super exciting and the process doesn't happen over night. Do your due diligence, but from what I have seen. LCTX has proven to be a legit entity operating with integrity. I believe their results.
LCTX is one of those high-risk, high-reward bets that I’m personally backing. The biotech / cell-therapy angle gives it real upside if their clinical programs hit. With analysts already putting it at $4.25, I think there’s strong potential.
As of close 9/26 Friday price is at 1.71 per share , up 234% YTD , i love waking up and seeing +thousands of dollars , this stock has serious potential with everything they have going on , LCTX to the f moon boys
This topic is the reason I am holding on to JOBY and LCTX for as long as possible.
MVST !!!!!!!!! I was right about BITF, LCTX and ...MVST !!! You got in in those dip, you did make over 100% !!!!
What do you think of $LCTX? I’m up 40%
LCTX - low risk, high reward!
LCTX, steady gains since market open
I am in deep, hoping LCTX gets bought out at a higher price point, at a little bit later date. OpRegen just seems like an obvious slam dunk, just hoping the spinal cord stuff they are working on ends up being as successful. If they push off selling, then they probably have a lot of faith in it.. for whatever that is worth.
If you want a penny stock with an actual business behind it LCTX.
LCTX around $1 and up over 10% today - unsure what's triggering it
LCTX - Making the blind see and the paralyzed move again with stem cells
LCTX - Roche moved a mover and shaker to lead the development of OpRegen to pivotal trials and FDA Approval. All signs point to buyout and blowup of the shorts.
Why a phase 3 may be needed for FDA approval, if P1/2a results are already solid at 36 months readout? How long P3 may take? If P3 needed for NDA submission, when the drug can be in market? Maybe 2030? Also, any idea how expensive LCTX cell therapy could be? And how large the addressable US market could be considering competition from already approved drugs like Syfovre and Izervey, admittedly OpRegen must be the most effective option?
I made some more calls last night, **SNGX** nice pump, **VRAX** decent so far, expected more from **CALC** and **BEAT** but green is green. I spend a bit of time looking for plays for y'all, even if I don't have time to play them myself, so if y'all gain or lose money on them, let me know so I can improve. I'll continue to work hard to hopefully help everyone make something. Thanks! Still long on **EONR, BLNE, LCTX, UROY, PRPL**
I've been burned by several local companies so I gave up on that route. I am rarely long on penny stocks but EONR/PRPL/LCTX/UROY/BLNE are on my radar
Seriously, I thought I sold all the stock out of a brokerage account, but still had some CBAY (CymaBay Therapeutics), that never hit the limit within the 60-days I guess.. just forgot about it. ended up getting a tax statement in the mail, and said what the hell.. lol ended up making some of the biggest gains ever due to their sale to Gilead. I plan to hold LCTX until they are bought out by Roche Genentech, or they go to zero. I would consider this high risk against the over all market, but when I stack them against other's in this industry.. Its hard for me to find a better place to put some money.
LCTX and this one isn't even speculation. It's a matter of WHEN not IF on this one.
Didn't have a lot of time to look and nothing really stood out as a great pick. **BRN** If this hits 1.10 it may be good to load. Proxy battle ongoing with Sherwood. **SGMO** Chart Is looking like a dip PM or around open, and I'd expect 10% up after. **GVH** Shorts are in heavy. Watch for covering over the next couple days. **UPXI** Will either correct up for 10% or go down another 10 to 20%. I'm still long on BLNE and LCTX.
Yes, Roche has licensed the rights to Lineage Cell Therapeutics' (LCTX) eye drug, OpRegen, for the treatment of geographic atrophy (GA) in patients with dry age-related macular degeneration. The deal involves an upfront payment of $50 million to Lineage, with potential milestone payments reaching up to $620 million. Lineage will also earn double-digit royalties on sales. Here you go buddy
I know many don't look at penny stocks for long term, but here's a few I've been mentioning and like: **LCTX** Thanks u/SushinWasabie **BLNE** **UROY** Other possible: **EONR** once they finish the inevitable round of funding and announce workover or additional roll-up **PRPL** if we get more news that looks like M&A progressing
**GNPX** At 90D support level near 52w low as of today, may bounce tomorrow *but could continue down* **MBRX** Offering closed, should recover some tomorrow with the 1 year cash runway at current burn rate **MSAI** Nothing special here but looks like it might dip some further and rebound tomorrow. Decent company with high insider and institutional ownership. **WINT** Possible small recovery but likely will continue down **LCTX** Long on this one, looking like the FDA will ease up given the reduction in risk. It's been climbing.
likely heading to buyout. Lots of tea leaves indicate Phase III soon, but it’s doubtful Roche allows LCTX to get too big, or another partner, before ponying up cash and stock.
LCTX is going to be huge, in my opinion. What do you think?
We all just going to ignore my boy LCTX like this, like they didn't just announce amazing 36 month results with OpRegen. AMD is going to be a health issue of the past.
It’s obviously LCTX, open your blind eyes. Are you a stupid sandwich as well?
Can't tell you its a good time to buy necessarily, unless you get in fast. I am excited to watch $LCTX and $NINE stock today. LCTX just announced positive results for OpRegen this weekend and well Oil prices are going up... so Nine should kill it this week.
LCTX Doesn’t really matter though, looking through the post history he made like $100
[https://stocktwits.com/symbol/LCTX](https://stocktwits.com/symbol/LCTX) Get in the family on stocktwit !
Just wanted to shoutout my worst stock, starting to look like a winner. $NINE; Oil/Gas - US based. The price of Oil is rising with this conflict in the middle east, if this continues to increase oil prices... well $NINE is going to be a major winner. Other stock I follow with a near term catalyst is $LCTX, announcing results of Phase 2 trials of OpRegen 20th or 21st of June (tomorrow or next day). This is going to hurt them bad or see major gains, you can do your own due diligence to determine the risk.
For real everyone knows $LCTX, $NINE, and $BBAI are the picks of the week, geez.
Been keeping an eye on LCTX, anyone any thoughts?
LCTX - reversing age related macular degeneration. Shares were heavily shorted following an offering. Ripe for a buyout from partner Roche as they look to kick off a pivotal trial.
go all in on BBAI, NINE, and LCTX got it.
I bought LCTX at the 52-week low after the share offering and I'm already up 20% ala $5000. Actually nuts.
I am a big believer in LCTX's solution to this problem and their ability to scale. Great analysis, really appreciate it.
Congrats! Stem cells…. LCTX!
Fresh catalyst: Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for serious neurological conditions, today announced that Brian M. Culley, Lineage’s Chief Executive Officer, will be presenting at the Oppenheimer 35th Annual Healthcare Lifesciences Conference on February 11, 2025 at 12:40pm ET. The conference is being held virtually February 11-12, 2025.
If anyone is interested, check out LCTX.
LCTX - almost done with stem cell therapy ph2 trial with Roche GALT - will release trial results by 1/1/25. See MDGL for comp. GFGSF - there’s gold in them hills!
In LCTX for 30,000 shares
Watching LCTX today. They have a catalyst on May 3 -- a clinical data release at a conference. The stock could go upward. Baird gave it a 270% upside -- [https://finance.yahoo.com/news/2-strong-buy-penny-stocks-173034915.html](https://finance.yahoo.com/news/2-strong-buy-penny-stocks-173034915.html)
Guys, check out LCTX, Baird just gave it 270% upside -- [https://finance.yahoo.com/news/2-strong-buy-penny-stocks-173034915.html](https://finance.yahoo.com/news/2-strong-buy-penny-stocks-173034915.html)
Guys, check out LCTX, Baird just gave it 270% upside -- [https://finance.yahoo.com/news/2-strong-buy-penny-stocks-173034915.html](https://finance.yahoo.com/news/2-strong-buy-penny-stocks-173034915.html)
Stocktwits. Some guys that is on our LCTX page mentioned LUNR and the likelihood of predictable gains based on SpaceX’s history. Just getting to lift off was a major boom for the stock. Still have some LUNR and LUNRW.
$LCTX $GERN $SLS are your 3 winners to be! :)
My Current Plays: Total $90K invested $SLS - Micro-cap - $24.3M with 9.5% short interest, Avg. Volume (3m): 975K \- Own 20,000 shares, $30,000 investment $LCTX - Micro-cap - $171.5M with 4.5% short interest, Avg. Volume 703K \- Own 30,000 shares, $40,000 investment $GERN - Smallcap - $993M with 8.66% short interest, Avg. Volume 5.6M \- Own 10,000 shares, $20,000 investment
Whats the play!!! $LCTX $GERN $SLS are super tightly shorted. Which one should we go after shorts on?
LCTX - curing blindness with stem cells.
$LCTX -- Yesterday it surged 10%... On watch for this morning. One analyst gave it 280% upside -- https://finance.yahoo.com/news/2-strong-buy-penny-stocks-144531039.html
As another guy said, financials don’t really matter for small biotech companies. For the most part they are all bleeding money. What you want to look for is if they have big backers that will cover future development for the foreseeable future if/when they hit their clinical milestones. LCTX has this When playing biotech stocks look for upcoming press releases (trial results), FDA approvals and buyouts. The stocks jump big on these and you should time your purchases/sales in anticipation of these events. Other things to look for are target population. Their phaseII opRegen has a very good market. I personally don’t invest in any Biotech companies focusing on rare diseases.
LCTX --- Looks like a breakout here... It's a small biotech firm with the back of healthcare giant Roche. Seem like analysts on average give it about 300% upside... Keeping this one on watch -- [https://finance.yahoo.com/news/2-strong-buy-penny-stocks-144531039.html](https://finance.yahoo.com/news/2-strong-buy-penny-stocks-144531039.html)
Guys, check out LCTX --- this analyst gave it 280% upside -- [https://finance.yahoo.com/news/2-strong-buy-penny-stocks-144531039.html](https://finance.yahoo.com/news/2-strong-buy-penny-stocks-144531039.html)
LCTX is a favorite - clinical-stage biotechnology company working on regenerative medicine. Working on spinal cord injury repair and collaboration with Roche and Genentech for dry age related macular degeneration.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: LCTX. Message /u/zjz if they're above 500 million-ish market cap and not related to crypto/pennies/OTC.
Anti-aging and life extension companies I believe will be have the biggest returns. Companies like AGE, UBX, LCTX. As soon as we can get an accurate biomarker(s) of aging and show that it’s possible to reverse it, money is going to flood in
Uxin, BB, EVFM, Atos, SNDL, ZOM, LCTX, Uone, AMC…fuck lol. 😂😭
Take a look at LCTX. It hasn’t run yet and they just posted some amazing news today. https://www.streetinsider.com/dr/news.php?id=20005606&gfv=1
LCTX- The news was just released today and it hasn’t mooned yet. https://mobile.twitter.com/home
I posted about CRXT this morning and now it is mooning. I also like LCTX to run within the next 10 days.
Just because 100 baggers are crazy hard to find, I'd go for an Anti-aging stock like LCTX, AGEX, UBX. Although there's no way to know where a big breakthrough could come from. It could completely transform the industry if an anti aging treatment came out that truly prevented the aging of cells. And it would certainly be acquired by a large pharma as it would hurt the revenues of almost all other drugs.
Cleveland Cliffs (CLF) looks undervalued. You may be able to catch a dip going into this weekend. I believe their earnings is next week and I'm confident they will crush revenue, profit, and guidance expectations. I would also anticipate to see them announce another large acquisition in the first half of 2022. I'm expecting to see the stock price between $22-$25 over the next three months, conservatively. GameStop (GME), despite it's rich valuation, looks like it's set for a strong reversal, based on technicals. I could see it easily rebounding to the $225-$250 range, over the next few months. Their earnings, toward the end of March, should show robust holiday sales, especially driven by multiple limited realeases of PS/XBOX consoles. They have a billion dollars in cash, minimal debt, and a strong investor base (similar to Tesla). Also, they share a strategic partnership with Microsoft and are developing an NFT marketplace, which could have huge implications for the gaming world. If you're looking for a high-risk, high-reward homerun play, I would look into speculative biotechs. The whole sector is way oversold, with major pharmaceutical companies having consolidated the lion's share of capital. In this market climate, with rising inflation and expected rate hikes, I expect to see the larger companies laying out their cash on M&A deals. My three favorites are Albireo Pharma (ALBO), Lineage Cell Therapeutics (LCTX), and Progenity (PROG). All three boast impressive patent portfolios and are de-risked, IMO. I think any of these are prime acquisition targets, with the possibility of netting a 5x-10x ROE, with an M&A deal. Obviously, this is a much riskier approach.
Let’s c…AMC, SNDL, ATOS, LCTX, BB, ZOM, UONE, UXIN. These fuckers haven’t seen green since the day I bought ‘em.
MVIS for metaverse play (AR/HoloLens), GME for NFT marketplace, PROG for its robust patent portfolio (especially OMDS), ALBO for PFIC treatment, and LCTX for regrowth of ocular/spinal tissue and gain of lost function.
LCTX GNPX next GME
LCTX - I'd love to see them succeed in repairing spinal cord injuries
LCTX hit the trifecta this week; dark cloud cover, falling three methods and three black crows. Falling star the last two days as well. That is as sick as a stock can look in a single week, guess it still has Friday to go.
Put your cash in LCTX. Happy 2022.
PROG. The patent portfolio is undervalued, relative to the market cap. Oversold, underappreciated. I also like ALBO, DRIO, BTAI, LCTX, and AYTU.
Had LCTX calls expire in the money as well.. I’ve read that it’s rare but it does happen.. lucky us sell CC Monday morning and hope it repeats lol
Still riding this out for a while. Once market corrects,looking at CLF, TSM, ALBO, BTAI, and LCTX.
I like TSM, CLF, ALBO, BTAI, DRIO, BTAI, and LCTX, over the next several years. However, I'm staying in these negative-betas until market corrects price discovery, or worse.
If you like TRVN check out LCTX too
$PRTK I made some on. It’s a buy at $5 currently. $Pfizer I made a lil on, but sold. $LCTX is at a buy level, made some $, bought back in. $VGNAF is cheap… I listed ones I made $ on or hold n don’t seem to b scams.
Can we talk about a stock you probably haven’t heard of? LCTX! This is my DD. JP Morgan just buy 1 million shares at 2.63. They are literally curing blindness. That had earnings today and business update. This is a 5 year play with 1000%…. This is investing. Bio tech.
LCTX is a great opportunity this week. They will be releasing Q2 financials and progress updates on Thursday. Their products in development seem promising.
While I agree that these companies are overvalued, I also support the unpopular opinion of consolidating your portfolio into high-conviction picks. I would say to do some valuation models (considering multiple approaches) and risk analyses with your picks. I think you can find better value/growth picks and M&A targets in each of these sectors. With that being said, I don't believe in diversification (especially if you're younger) because it can water down/cap your results. This is a good model for high net worth investors, as the growth on the arbitrage compounds, while reducing risks in any single stock. High concentration in quality picks can drastically change your results, in your wealth growth stage. So, it all depends on your time horizon and risk aversion. Personally, I only ever hold a handful of stocks, in which I have done extensive research on and feel have room for large price appreciation. I establish valuation models relative to peers, based on TAM, revenues growth, debt/cash stability, enterprise value, and margins, to name a few. I also consider non-financial factors, like management, M&A probability, and economic moat (competition). I chase multiples, not percentage gains; meaning I look for which stocks are most likely to double, triple, etc. my investment. I currently hold 5 stocks, none of which I can post here, due to sub rules. My portfolio is up around 250% this year, 700% from a year ago. Some of my previous winners were AMD (900%), CRON (400%), CVRS (350%), LVGO (450%), and LCTX (350%).
LCTX 3/4 patients with Dry AMD showed retinal regeneration and visual acuity improvements in last data shared with OpRegen study. 3 pipelines, VAC2, OPC1(spinal cord injuries, no known treatment) and OpRegen (Dry AMD), based on cell transplant technology (not gene editing).
LCTX for retinal tissue regrowth and spinal injury therapeutics. Excellent trial data readouts and still extremely undervalued. TSM because they will be the obvious winner of the chip war. GME for their revolutionary rebirth under Ryan Cohen.
Guys. I really want to do an in-depth DD on a bio stock called LCTX. That being said I don’t have a lot of work ethic so instead I just come to the daily to pump my stock. Like no joke. This stock will be 50-100 bucks in five years. It’s currently 2.90. LCTX. They are curing blindness. Check them out. Just hit Russel 3000
LCTX is climbing after a small lunch time dip